Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Granisetron ECG effects in breast cancer surgery
NCT01352130Phase 4Completed
- Sponsor
- Tata Memorial Hospital
- Start
- Mar 2007
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in postoperative nausea and vomiting (PONV) comparing Ondansetron with Granisetron (2 arms). Primary endpoint: Corrected QT interval at 2 hours. Started Mar 2007; status: completed.
02
Drugs
ondansetrongranisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01352130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352130.